Name: Alzheimers 2021
Start: 2021-09-03
End: 2021-09-05
Location: France

Conference Information

You are invited!!

In continuation with the past “Dementia Conference 2019” Pulsus group proudly invites all the participants and sponsors across the globe to participate in the “12^th International conference on Dementia and Alzheimer Diseases” (Alzheimers2021) which will be held during September 03-04, 2021 at Paris, France.

The main focus of our conference is to bring the renowned neurologist, neurosurgeons, researchers, health care professionals and special educators under a single place to share their knowledge and scientific progress in the field of dementia and Alzheimer diseases in the theme “Confront and Allay Dementia through miscellaneous Pedagogy during COVID19”

Our conference includes a well-balanced line up of speakers, covering both broad specific topics of interest. Our aim is to provide the neurosurgeon, specialists and anyone professionally involved in dementia diseases with an opportunity to learn about the complex nature of the diseases, understand the local realities and discover better remedy for the dementia conferences, we hope that you will grab the opportunity and associate with us.

This year’s conference is no exception and brings together alzheimers, dementia, neurology, psychiatry researchers, professors, students, delegates from across the globe to discuss the latest advances in this vibrant and constantly evolving field of Alzheimers and Dementia.

We hope that the event will challenge and inspire you,and results in unveiling knowledge, friendships, and collaborations, despite the stimulating program you will be able to enjoy the exotic and vibrant atmosphereof Paris.

Looking forward to catching up with you at the "City of Lights"!!!

Scientific Sessions

TRACK 1: DEMENTIA

Dementia is a syndrome in which deterioration in the memory, thinking and causes other problems in the brain. Dementia mainly affects the older people rather than younger people. In the every year, 10 million peoples are affected by dementia and joining as a new case. In Worldwide, 50 million peoples are affected by dementia.

Dementia affects the people in physiological, psychological and social activity. Dementia affects each person in different way, based upon their personality changes and other behavioural changes dementia can be identified. The three stages of dementia are early stage, middle stage and last stage.

In the early stage of dementia, people gradually lose their character and starting some changes in the behaviour. In the middle stage dementia somewhat seen clearly by some of the symptoms. The last stage is the severe stage, it cannot be cured.

People with dementia are frequently loses their basic rights and difficult to lead the normal life. The families of affected people also suffer a lot to survive. They face many problems in the society in physical, mental and social pressure. The seven stages of syndrome are,

No impairment
Very mild cognitive decline
Moderate cognitive decline
Mild cognitive decline

TRACK 2: NEUROLOGY

Neurology is the branch of medicine that deals with the study of nervous system in the brain. If any problem in the axon and the outermost coverings it leads to the loss of data or loss of impulse to other areas. This leads to the loss of memory functions like dementia and Alzheimer. Neurology accompanied with the central nervous system and peripheral nervous system. Peripheral nervous system contains all nerves outside of the nervous system. The departments comes under neurology are,

Neuro genetics
Neuropharmacology
Neuro immunology
Neuro paediatric
Neuro psychiatry
Neurological nursing
Neuro imaging
Neuro radiology

TRACK 3: NEUROSURGERY

Neurosurgery helps to cure the nerve related problem and retain patient to the normal state. Neurosurgeons are broadly classified into three types; they are paediatric neurosurgeon, functional neurosurgeon and oncology neurosurgeon. Paediatric neurosurgeons are used to treat the facial bones in the skull, tumours and congenital spine defects. Functional neurosurgeons are used to manage the conditions like epilepsy, movement disorder and palsy. Oncology neurosurgeons are used to manage the brain and spine tumours.

Paediatric neurosurgeon
Functional neurosurgeon
Oncology neurosurgeon

TRACK 4: NEUROPHARMACOLOGY

Neuropharmacology is used to study the characteristics of drug interaction with the cells present in the brain. The drug interaction with the cell in the two forms, Behavioural and Molecular. Behavioural neuropharmacology is used to study the drug function in the brain and find how it changes the human behaviour.

Molecular pharmacology involves the study of neurons in the brain and finds the neurochemical interaction between the each neuron. The main goal of developing drug is to get some beneficial effect on neurological functions.

Behavioural neuropharmacology
Molecular pharmacology

TRACK 5: NEUROLOGICAL DISORDERS

Neurological disorder is the any disorder in the nervous system and causes problems in the brain and the spinal cord. It changes the biochemical actions of the brain cells and leads to variation in the structure.

Amyotrophic lateral sclerosis is the progressive neurodegenerative disease that causes defect in the brain cells and the spinal cord. The amyotrophic is comes from Greek language A means No, Myo means Muscle and Trophic means Nourishment, amyotrophic means No Muscle Nourishment.

Aneurysm refers to weakening of an artery valve leads to the bulging of valves or distension that further creates the rupturing of artery valves leads to the life threatening conditions. In some cases it doesn’t show any symptoms and it may not cause any dangerous, it suppressed.

Motor neuron diseases.
Prion diseases
Schizophrenia
Autism child.
ADD and ADHD.
Insomnia.

TRACK 6: NEURODEGENERATIVE DISEASES

Neurodegenerative disease is the progressive degeneration of the central nervous system and peripheral nervous system. This progressive degeneration collapses the function and structure of the brain. The common neurodegenerative diseases are Alzheimer’s diseases, Parkinson’s diseases. Neurodegenerative diseases are incurable conditions that result in progressive degeneration of nerve cells.

Spinal muscular atrophy is a type of neurodegenerative diseases. This causes the loss of motor neurons and muscle wasting. It is leading genetic cause death in the infants. Prion diseases are also a type of neurodegenerative diseases. It is caused due to the pertinacious infection particle. It is caused due to the folded forms of protein molecules.

Multiple sclerosis is the disease in which the immune system eats the outer most covering of the nerve cells. In this case the treatment can to prolong the life, it cannot be cured. The symptoms of multiple sclerosis are vision loss, fatigue, pain and impaired coordination.

Amyotrophic lateral sclerosis
Aneurysm
Multiple sclerosis
Spinal cord injury.
Spinal muscular atrophy

TRACK 7: TYPES OF DEMENTIA

Dementia is a nerve related problem, it causes serious injuries and nerve related problems in brain. This disorder is broadly classified into various types; they are Alzheimer’s diseases, lewy body dementia, front temporal dementia, Wernicke korsakoff syndrome like that the major syndrome are present. Alzheimer is the most common type of syndrome in the dementia.

Wernicke korsakkof is the severe phase of the dementia and another form of this disorder is encephalopathy. It is the deficiency of the vitamin B thiamine. Parkinson diseases affect the movement of the person, often including tremors.

Huntington is the serious condition in which the nerve cells in the breakdown over time. It typically starts in a person of 30’s and 40’s. Physiotherapy and talk therapy helps to cure these diseases

Alzheimer’s diseases.
Lewy body dementia.
Frontotemporal dementia.
Wernicke korsakoff.
Parkinson’s diseases.
Huntington’s diseases.
Creutzfeldt-Jakob diseases.

TRACK 8: VASCULAR DEMENTIA

Vascular dementia is a general term describing the problem based on reasoning, planning, judgement, memory and other thought process caused by the brain from the damaged blood vessels. This disease is mainly happened in the older people with the obesity and diabetes. It is mostly caused at the higher risk of stroke.

It mainly affects the heart health, the seven stages of vascular dementia are, memory loss, communication problem, concentration problem, visual perception problem and judgement problem. Alzheimer drugs may help to control cognitive syndrome. Vascular dementia stops the arterial blood flow in the brain.

Each person experience different form of dementia based upon their body conditions. On average people with vascular dementia live for around five year after the symptoms begins

Vascular cognitive impairment.
Neurovascular dysfunction.
Geriatrics care practice and awareness neuroscience.

TRACK 9: AMYLOID PROTEIN IN DEMENTIA

Amyloid protein forms the plaque or neurofibrillary tangle like structure. Neurofibrillary tangles are insoluble twisted fibres formed in between the brain cells. This causes the degradation of the neurons and shows the symptoms of the Alzheimer’s diseases. Alzheimer diseases are caused due to the accumulation of plaques in between the nerve cells in the brain. In the healthy brain, the protein molecules are break down and getting eliminated. The protein molecule is abnormal in the Alzheimer diseases causes collapse in the brain cells. The treatments for the amyloid protein are,

Amyloid plaques and neurofibrillary tangles
Cerebral Amyloid Angioplasty
Cerebrovascular Pathology
Cellular Signalling and cellular to cell transmission

TRACK 10: DEMENTIA NURSING

Dementia nursing provides the care for the dementia patient and improve their quality of life by giving some guidance. And also give some guidelines for their care taker. Dementia nurse improve the mental quality of the dementia patient. Dementia nurse take care of the conditions like, risk for trauma, chronic confusion, self-care deficit, risk for falls.

The nursing intervention for the dementia patient, orient client, encourage care givers about re-orientation, enforce with positive feedback, explain simply, Discourage suspiciousness of others, Avoid cultivation of false ideas, Observe client closely. The nursing management of a client with dementia include,

Nursing assessment.
Nursing diagnosis.
Nursing care planning and goals.
Nursing interventions.

TRACK 11: IMAGING TECHNIQUES FOR BRAIN

Imaging techniques play a major role in the detection of dementia diseases. Equipment used for the imaging techniques of dementia are Magnetic Resonance Imaging (MRI) and Computed Tomography (CT). This equipment’s are used for the diagnostic purposes. Both the machine shows the high resolution brain images for diagnostic purposes.

MRI fined the loss of brain mass using scanning techniques along with Mild Cognitive Impairment (MCI). MRI can be used to detect the brain tumour, brain injury along with loss of brain mass. It also detects the stroke, multiple sclerosis and dementia.

More recently, the researchers quite a few imaging modalities, such as structural and useful Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) studies of cerebral metabolism. Some of the imaging techniques like,

Magnetic resonance imaging.
Computed tomography.
Positron emission tomography.

TRACK 12: DRUG DEVELOPMENT IN DEMENTIA

Dementia has only little treatment to control and cure the patient and lots of treatment gone failure. Drug development for the dementia is the tedious one. The first drug was approved in the year 2003 and there is no other approval for the dementia drug development. So the drug development for the dementia is going to be complex.

A new research on dementia is going on using the amyloid, tau and neurodegeneration condition in the national institute of aging. This frame work produces the more stages of dementia. The clinical trials of Dementia are helpful to understanding the roll of the positron emission tomography.

The drug discovery mainly focus on the repurposing of the drugs, which means the drug is already used for many other conditions and this medicine is again used for the dementia with some modification in that chemicals. The drugs developed for dementia are

Gantenerumab
Solanezumab

TRACK 13: ANIMAL MODEL AND TRANSLATIONAL MEDICINES

Animal models are the big trust for the researchers to find the medicine and check with that in the animals like testing mouse. In the animal model only support the Alzheimer diseases and closely connect the front temporal diseases. So mostly do the research in the Alzheimer diseases. Patients with Alzheimer’s illness can show the amyloidopathy and tauopathy.

Even though the anatomy of mouse is different than the human, the participant value is added. This has crystal rectifier several corporations to specialize in antibodies that block neurodegeneration in these mouse models.

Animal models of human psychological feature aging
Development of latest animal models
Genetic science of translational models
Protein-protein interactions

TRACK 14: DEMENTIA REHABILITATION AND THERAPY

The people suffered by dementia losses their past activities and forgot the past enjoyment. Problem with memory loss can make a people more difficult to lead their everyday life. Cognitive rehabilitation is a type of therapy which is used to recover the dementia patient.

Physical therapy and rehabilitation services have many benefits to improve the quality of life from the dementia and Alzheimer. This service is helpful to relieve the patient from the disease and improve the quality of life. The physical therapist treatment includes the exercise. Some of the types of rehabilitation therapy include,

Occupational therapy.
Speech therapy.
Physical therapy.

TRACK 15: SYMPTOMS OF DEMENTIA

Dementia is identified by using some symptoms like problem with short memory, anxiety, depression, hearing impairment and headache. The short term memory loss is impact due to the concussion and trauma to the head. Medical conditions like seizures, epilepsy, heart bypass surgery and depression can also impact short-term memory.

The disorder can cause an increase in heart rate, shakiness, palpitations, chest pain and high risk in the blood pressure. People with anxiety disorders have hormone changes and defect in the chemical messenger areas. Anxiety attacks usually last in 10 minutes but it even may prolong for 30 minutes. During anxiety, the person loses their control at the short period of time.

It is the temporary mood caused by the life events and grieving. Depression can affect a person psychologically and it has the potential to change the physical structures of the brain.

Problem with short term memory
Anxiety problem
Depression leads to some effects Hearing impairment

TRACK 16: CAUSES OF DEMENTIA

Dementia causes major disorders in that the main causes is aging, heredity and family history. Dementia mostly affects the aged people of above 60. But it also affect the young people of the ages 30’s, 40’s and 50’s. In this age progress, slow down the mental function and lead to dementia. These types of memory related diseases are mostly caused due to genes and it carried from one generation to another generation.

If anyone have problem related to disorder in the family, it also exhibit in the next generation and causes dementia. And in this case, it causes the deterministic dementia.

Due to age
Genetics or heredity
Family history

TRACK 17: PREVENTION MEASURES

The foremost way to prevent the dementia is to maintain the normal body function and interact with the other people and do some activity. The other main way to prevent dementia is eat healthy food. Eating of healthy food reduces the risk of dementia, Avoid consuming of the fat rich content, Instead of that only use the fibrous food. It will increase the possibility of person living without dementia.

Exercise helps to increase the blood and oxygen flow in the brain and helps to maintain the normal mental state of the person. Diet also helps to increase the stable mental state. Avoid intake of the saturated fats and sugars.

Instead of that use plenty of whole grains, vegetables and fruits. The number of case studies shows that the strong connections with the social network reduces the risk of dementia and relieve the mental stress. Due to this social interaction, it strengthens the connection between the nerve cells in the brain

Physical exercise and diet
Social connection and intellectual activity
Eat healthy food

TRACK 18: CARE PRACTICE AND AWARENESS

In the dementia care practice and awareness session, the care taker should concentrate on the physical conditions and the food. It is the main thing that every care taker should follow to recover the dementia patient.

The first care for the patient is to give the healthy food and maintain the diet, consume large amount of fluid items and fibrous fruits instead of the fat content. The second care is to connect the dementia patient with the social network and try to change their mental state.

Care taker should continuously monitor the dementia patient and take care of their food schedule. Care taker not only follows the physical condition and also follows the mental condition of the patient. The steps should follow by the care takers includes,

Dementia Nursing
Psycho-Social Interventions
Cognitive Training
Dementia Management
Dementia Care Advances using Cloud Technology
Assistive Health Car

TRACK 19: CLINICAL TRIALS AND CASE REPORT

The goal of research on the dementia is to develop the medicine to recover them from the problem. It is occurred in all over the world. The clinical trials are done to check whether this method is safe or unsafe for the patient. Without the clinical research and care taker there is no treatment for the dementia.

Medications called cholinesterase inhibitors are prescribed for mild to moderate dementia diseases. These drugs may help to cure the problem or suppress the problem. There is no standard treatment for dementia, but some of the measures to maintain the mental state of the patient.

Aducanumab is a monoclonal antibody an expensive drug to cure the dementia diseases. Function behind this method is that protein molecule bind with the drug to cure them. It is given through the intravenous vein once in a month. The antibodies used here is

Aducanumab
cholinesterase inhibitors

TRACK 20: CURRENT RESEARCH IN THERAPEUTIC TARGETS

In 2018, the expert opinion on therapeutic target is increased by 4.621 and it is 0.5 increased in the year 2019. Studies have shown that amyloid-β (Aβ) protein deposition is an early event that may be in the development of Alzheimer’s, but the mechanisms that link Aβ to neurodegeneration are poorly understood, so require more research.

The report also states that clinically-relevant symptoms tend to appear at the same time as tau pathology is correlated with cell death, meaning that prevention of the disease is difficult to study.

Furthermore, some parts of the brain such as the hippocampus and amygdala seem to show a selective weakness to plaque accumulation and tau-associated neurodegeneration, while others like the cerebellum are initially spared. The list of improvements for dementia research includes:

Encouraging early drug discovery to identify targets
Investigating the effects of genetic risk factors on disease
Improving understanding of brain nerve cells are more resilient than others
Ensuring the right selection for clinical trials
Improving ways to measure the efficacy of drugs
Finding ways to begin clinical trials decades earlier than is currently conducted.

Market Analysis

Dementia Market recently every 3 seconds one person on this planet develops dementia. Dementia is the syndrome which causes memory loss, and leads to the problem in the brain. The most common form of dementia is Alzheimer diseases. It mostly exists for the older age people. It may also come for the younger people based upon their body condition.

Before 1990 the rate of dementia is less, but in the year of 1990 to 2016 it increased 117% globally, according to the study findings. The number of dementia rate increased from 20.2 million in 1990 to 43.8 million in 2016 between 1990 and 2016. In 2017 case study, 46.8 million individuals are living with Dementia and this number is increased to 50 million in the year of 2019.

The market evaluation of diverse reports says that the combination estimation and overall fee of dementia is US$818 billion as of 2017, which signify about 1.09% of worldwide GDP. Around 2021, the worldwide price of Alzheimer’s will blow up to a trillion dollar from $818 billion. The reports have shown that dementia alone has increases through 35% seeing that 2010.

The document updates on Alzheimer’s disease International’s (ADI) records on dementia’s global prevalence, prevalence and cost, highlighting dementia’s increasing effect on low and middle earnings countries (LMICs). This discern incorporates fees credited to casual care and synchronizes charges of social care and the immediate charges of medicinal care, the direct scientific care expenses about 20% of global dementia prices, whilst direct social sector expenses and casual care prices each account for about 40%.

Top Hospitals in France:

American Hospital of Paris
Amiens university Hospitals
Angers University Hospitals
Broussais University Hospitals
Les Invalides
Hôtel-Dieu
Hôpital Européen Georges-Pompidou
Groupe hospitalier Diaconesses Croix Saint-Simon
Rothschild Hospital
Pitié-Salpêtrière University Hospital

Top universities in France:

Pantheon-Sorbonne University
University of Paris Nord
Panthéon-Assas University
New Sorbonne University
Paris-Sorbonne University
Pierre and Marie Curie University
Paris Descartes University
Paris Diderot University
University of Vincennes in Saint-Denis

12^th International Conference on
Dementia and Alzheimers Disease

Quick Links

Theme: Confront and Allay Dementia through miscellaneous Pedagogy during COVID-19